¹Ì±¹ÀÇ Á¶Á÷ Áø´Ü ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ±â¼ú ¹× Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
U.S. Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology & Product (IHC, Primary & Special Staining), By Application (Breast Cancer, NSCLC), And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1631209
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ Á¶Á÷ Áø´Ü ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹ÀÇ Á¶Á÷ Áø´Ü ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 44¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2030³â ¿¬Æò±Õ 8.3%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ½ÃÀå ¼ºÀåÀ» º¸¿ÏÇÏ´Â Áß¿äÇÑ ¿äÀÎÀ¸·Î´Â ¾Ï ȯÀÚÀÇ Áö¼ÓÀûÀÎ Áõ°¡, Àå±â ÀÌ½Ä ¹× Àå±â ±âÁõÀÇ Áõ°¡, ¹Ì±¹ ³» ¸ÂÃãÇü ÀÇ·á ¹× µ¿¹ÝÁø´Ü¿¡ ´ëÇÑ ¼ö¿ë¼º Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù.

ÇØºÎº´¸®ÇÐ ºÎ¹®Àº ¹Ì±¹ ³» ¾Ï ¹ßº´·üÀÇ ±Þ°ÝÇÑ Áõ°¡·Î ÀÎÇØ ÆÐ·¯´ÙÀÓÀÇ º¯È­¸¦ ¸ñ°ÝÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÐÀÚ º´¸®Çаú ÇØºÎÇÐÀû º´¸®ÇÐÀÇ ²ÙÁØÇÑ À¶ÇÕ, ¾Ï °ËÃâÀ» À§ÇÑ »õ·Î¿î »ý°Ë¹ýÀÇ ºü¸¥ äÅÃ, µðÁöÅÐ ±â¼úÀÇ ÅëÇÕÀÌ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶Á÷ ºÐ¼®Àº ±âÁ¸ÀÇ ºÐÀÚ ±â¼ú·Î´Â ÀÌÇØÇϱ⠾î·Á¿î Áß¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖ½À´Ï´Ù. ÇöÀç, µ¿¹ÝÁø´Ü °Ë»ç´Â Á¦¾àȸ»çµéÀÌ ÀÚ»ç Á¦Ç°ÀÇ 1Â÷ Ä¡·áÁ¦ ÁöÁ¤/½ÂÀÎÀ» ȹµæÇϱâ À§ÇØ ºü¸£°Ô äÅõǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ç¥Àû Ä¡·áÀÇ È¿°ú°¡ ±â´ëµÇ´Â ȯÀÚ ÄÚȣƮ¸¦ ½Äº°ÇÏ´Â µ¥ »ç¿ëµÇ¸é¼­ Á¤¹Ð ÀǾàǰ °³¹ß¿¡¼­ Á¶Á÷ Áø´ÜÀÇ Á߿伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Á¶Á÷ Áø´Ü ºÎ¹®Àº Çü±¤ ÇöÀå ÇÏÀ̺긮µåÈ­(FISH), ¸é¿ªÁ¶Á÷È­ÇÐ(IHC), ¸é¿ªÇü±¤(IF), ºñ±³ À¯Àüü ÇÏÀ̺긮µåÈ­, Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS) µî ¾÷±×·¹À̵åµÈ ±â¼úÀ» äÅÃÇÏ¿© Á¡Â÷ ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀº »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿ ¹ß±¼°ú ÷´Ü ¾Ï Áø´ÜÀ» À§ÇÑ ºÐ¼®¹ý °³¹ß¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¢ ¾÷üµéÀº ÃֽŠº´¸®ÇÐÀû ¼Ö·ç¼ÇÀÇ Ã¤Å÷üÀ» ³ôÀ̱â À§ÇØ ¹ÙÀÌ¿À¸¶Ä¿ º´¸®ÇÐÀÚ ±³À° ÇÁ·Î±×·¥À» ½ÃÇàÇϰí ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ Á¶Á÷ Áø´Ü ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ Á¶Á÷ Áø´Ü ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ Á¶Á÷ Áø´Ü ½ÃÀå : ±â¼ú¡¤Á¦Ç°º°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¹Ì±¹ÀÇ Á¶Á÷ Áø´Ü ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¹Ì±¹ÀÇ Á¶Á÷ Áø´Ü ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. Tissue Diagnostics Market Growth & Trends:

The U.S. tissue diagnostics market size is estimated to reach USD 4.40 billion by 2030, registering a CAGR of 8.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Pivotal factors supplementing the market growth include continuous rise in the cases of cancer, growth in organ transplantation & donation, and increased acceptance toward personalized medicine & companion diagnostics in the U.S. Increase in the number of research activities targeted toward the development of novel tissue diagnostics solutions is also expected to drive the market.

The field of anatomic pathology has witnessed a paradigm shift, which can be attributed to the exponential growth in cancer incidence in the U.S., thereby expanding the clinical pathology industry. Also, steady convergence of molecular pathology with anatomic pathology, steep adoption of novel biopsies for cancer detection, and integration of digital technologies is expected to collaboratively make a positive impact on market growth.

Tissue analysis provides significant information, which is difficult to understand using conventional molecular techniques. Currently, companion diagnostic tests are rapidly being adopted by pharmaceutical companies for obtaining first-line therapy designations/approvals for their products. In addition, their use in the identification of patient cohorts, which are likely to benefit from targeted therapeutics, has increased the significance of tissue diagnostics in the development of precision medicine.

In addition, the field of tissue diagnostics has witnessed gradual evolution with the introduction of upgraded technologies, including Fluorescence In Situ Hybridization (FISH), Immunohistochemistry (IHC), Immunofluorescence (IF), comparative genomic hybridization, and Next-Generation Sequencing (NGS). Key players are focused on identifying novel biomarkers and developing assays for advanced cancer diagnosis. Furthermore, companies are conducting biomarker pathologist training programs to boost the adoption rate of modern pathological solutions.

U.S. Tissue Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Tissue Diagnostics Market Variables, Trends & Scope

Chapter 4. U.S. Tissue Diagnostics Market: Technology & Product Estimates & Trend Analysis

Chapter 5. U.S. Tissue Diagnostics Market: Application Estimates & Trend Analysis

Chapter 6. U.S. Tissue Diagnostics Market: End Use Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â